MDMA-assisted therapy for stress in healthcare and first responders
Treatments studied
Part of Mental health clinical trials.
This Phase 2 study tests whether MDMA combined with structured therapy can reduce stress symptoms in people who have been exposed to major work-related stress in healthcare or emergency response. It’s designed to help participants during special “experimental” sessions plus regular therapy sessions without MDMA.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your work involved stressful events in healthcare or emergency response
- You can read and speak English and can swallow pills
- You agree to have study sessions recorded and to take part in therapy sessions
- You have a reachable support person if you become suicidal or can’t be reached
- If you can become pregnant, you must test negative and use birth control through 10 days after the last MDMA session
- You can follow study rules like fasting, avoiding certain meds, not joining other drug trials, and arranging rides home after sessions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether MDMA (the drug in ecstasy) combined with a type of talk therapy called massed exposure therapy can help treat PTSD. It may be an option if standard treatments haven't worked well enough.
This Phase 2 trial tests whether therapy assisted by MDMA can reduce symptoms of moderate to severe post-traumatic stress disorder (PTSD) in eligible veterans. It includes supervised therapy sessions and extra study visits with video recording to track changes over time.
This study tests whether MDMA (a medication) combined with therapy can help veterans with post-traumatic stress disorder (PTSD). MDMA may help people process difficult memories and emotions more effectively during therapy sessions.
This study tests whether MDMA, combined with a type of talk therapy called CBCT (cognitive behavioral conjoint therapy), is more effective than CBCT alone for treating PTSD. You and a close partner will both participate in therapy sessions and take MDMA together.
This trial tests if MDMA (a drug that can help with therapy) along with talk therapy can help military members with PTSD. It is designed for active duty, National Guard, or Reserve service members who have had PTSD for at least six months.
This Phase 2 study tests whether MDMA-assisted therapy can reduce adjustment-related distress in cancer patients who are paired with a loved one who is also concerned. It may help the patient and their significant other cope better through structured therapy sessions, with safety checks before and after each session.
Hear when a new PTSD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.